MIF and pancreatic ductal adenocarcinoma: The molecular mechanism of action by which MIF overexpression in pancreatic cancers is associated with very poor prognosis and marked cancer aggressiveness has been linked to inhibition by MIF of the orphan nuclear receptor NR3C2, that controls aggressiveness and survival in pancreatic ductal adenocarcinoma (PDAC).